Abstract:Plant styrylpyrones exerting well-established neuroprotective properties have attracted increasing attention in recent years. The ability to synthesize each individual styrylpyrone in engineered microorganisms is important to understanding the biological activity of medicinal plants and the complex mixtures they produce. Microbial biomanufacturing of diverse plant-derived styrylpyrones also provides a sustainable and efficient approach for the production of valuable plant styrylpyrones as daily supplements or potential drugs complementary to the prevalent agriculture-based approach. In this study, we firstly demonstrated the heterogenous biosynthesis of two 7,8-saturated styrylpyrones (7,8-dihydro-5,6-dehydrokavain (DDK) and 7,8-dihydroyangonin (DHY)) and two 7,8-unsaturated styrylpyrones (desmethoxyyangonin (DMY) and yangonin (Y)), in Saccharomyces cerevisiae. Although plant styrylpyrone biosynthetic pathways have not been fully elucidated, we functionally reconstructed the recently discovered kava styrylpyrone biosynthetic pathway that has high substrate promiscuity in yeast, and combined it with upstream hydroxycinnamic acid biosynthetic pathways to produce diverse plant-derived styrylpyrones without the native plant enzymes. We optimized the de novo pathways by engineering yeast endogenous aromatic amino acid metabolism and endogenous double bond reductases and by CRISPR-mediated δ-integration to overexpress the rate-limiting pathway genes. These combinatorial engineering efforts led to the first three yeast strains that can produce diverse plant-derived styrylpyrones de novo, with the titers of DDK, DMY and Y at 4.40 μM, 1.28 μM and 0.10 μM, respectively. This work has laid the foundation for larger-scale styrylpyrone biomanufacturing and the complete biosynthesis of more complicated plant styrylpyrones.

De novo biosynthesis of (S)- and (R)-phenylethanediol in yeast via artificial enzyme cascades.

De Novo Biosynthesis of 2-Phenylethanol by Metabolic Engineering the Oleaginous Yeast Rhodotorula Toruloides

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

The De Novo Synthesis of 2-Phenylethanol from Glucose by the Synthetic Microbial Consortium Composed of Engineered Escherichia coli and Meyerozyma guilliermondii

Metabolic engineering of a Saccharomyces cerevisiae strain capable of simultaneously utilizing glucose and galactose to produce enantiopure (2R,3R)-butanediol

Engineering yeast phospholipid metabolism for de novo oleoylethanolamide production

De-novo Synthesis of 2-Phenylethanol by Enterobacter Sp. CGMCC 5087

Multilevel metabolic engineering of Bacillus licheniformis for de novo biosynthesis of 2-phenylethanol

Metabolic engineering of the oleaginous yeast Yarrowia lipolytica for 2-phenylethanol overproduction

Yeast Metabolic Engineering for Biosynthesis of Caffeic Acid-Derived Phenethyl Ester and Phenethyl Amide

De novo biosynthesis of diverse plant-derived styrylpyrones in Saccharomyces cerevisiae

Multi-modular engineering of<i>Saccharomyces cerevisiae</i>for high-titre production of tyrosol and salidroside

Metabolic engineering of Saccharomyces cerevisiae for production of very long chain fatty acid-derived chemicals

De novo biosynthesis of bioactive isoflavonoids by engineered yeast cell factories

Genetic engineering of an industrial yeast Candida glycerinogenes for efficient production of 2-phenylethanol

Engineered Saccharomyces Cerevisiae for the De Novo Synthesis of the Aroma Compound Longifolene

De novo Synthesis of 2-phenylethanol from Glucose by Metabolically Engineered Escherichia coli

De Novo Production of Hydroxytyrosol by Metabolic Engineering of Saccharomyces cerevisiae

Rational engineering of Kluyveromyces marxianus to create a chassis for the production of aromatic products

Improvement of 2-phenylethanol production in Saccharomyces cerevisiae by evolutionary and rational metabolic engineering

Rewiring central carbon metabolism for tyrosol and salidroside production in Saccharomyces cerevisiae